Table 3.
Method | Target | Subject | Feature | Result (Corr) |
---|---|---|---|---|
Duchesne et al., 2009 | M12 MMSE | 75 NC, 49 MCI, 75 AD | Baseline MRI, age, gender, years of education | MMSE: 0.31 (p = 0.03) |
Stonnington et al., 2010 | Baseline ADAS-Cog and MMSE | Set 1:73 AD, 91 NC Set 2: (ADNI) 113 AD, 351 MCI, 122 NC | BaselineMRI, CSF | MMSE Set1: 0.7 (p < 10e-5) Set 2: 0.48 (p < 10e-5) ADAS-Cog Set 2: 0.57 (p < 10e-5) |
Zhang et al., 2012 | Baseline,M06,M12,M24 ADAS-Cog, MMSE | ADNI: 91 AD, 202 MCI, 152 NC | Baseline,M06, M12, M24 MRI | Average MMSE: 0.613 (p < 10e-5) Average ADAS-Cog: 0.639 (p < 10e-5) |
Proposed | Baseline, M06, M12, M24 ADAS-Cog, MMSE | ADNI: 91 AD, 202 MCI, 152 NC | Baseline MRI | Average MMSE: 0.7538 (p < 10e-5) Average ADAS-Cog: 0.7875 (p < 10e-5) |
AD, MCI, and NC denote Alzheimer's disease patients, mild cognitive impairment patients, and normal controls, respectively.